Medindia

X

ARIXTRA drug for venous thromboembolism

by Medindia Content Team on  February 5, 2006 at 11:01 AM Drug News   - G J E 4
ARIXTRA drug for venous thromboembolism
Venous thromboembolism is a complication causing increased bleeding which occurs after an orthopedic surgery procedure. Professor Clifford W. Colwell has reported in the Journal of Arthroplasty that by giving a dose of ARIXTRA drug to these patients who underwent orthopedic surgery the complications and amount of bleeding decreased.
Advertisement

ARIXTRA drug which is called as FLEXTRA (Flexibility in Administration of Fondaparinux for Prevention of Symptomatic Venous Thromboembolism in Orthopaedic Surgery) is found to have anti-thrombotic activity which helps in coagulation by increasing the coagulating factors is found to be very useful in these patients and the drug is administered in the morning the day after surgery when the risk of developing venous thromboembolism is high.

Advertisement
The drug ARIXTRA is manufactured by the pharmaceutical giant GlaxoSmithKline and is found to inhibit the factor Xa protein which is present in the coagulation cascade pathway and the drug is found to effectively control venous thromboembolism and pulmonary embolism in patients who underwent bone surgery for knee and hip replacement. The drug ARIXTRA is found to have very less side effects of causing bleeding, bacterial endocarditis and hypersensitivity but the benefits of the drug is more beneficial than its side effect.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All